---
title: "RxSight forecasts 2026 revenue of $140 million-$160 million, cuts sales outlook to $110 million-$120 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291840120.md"
description: "RxSight lowered its 2026 sales guidance to $110-$120 million from $120-$135 million but raised gross margin outlook to 73%-75%. The company forecasts 2026 revenue of $140-$160 million, including $30-$40 million from an Alcon collaboration. Operating expenses remain at the high end of $150-$160 million. Preliminary Q2 revenue is estimated at $32-$34 million, with cash holdings of $209 million as of June 30."
datetime: "2026-07-06T20:15:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291840120.md)
  - [en](https://longbridge.com/en/news/291840120.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291840120.md)
---

# RxSight forecasts 2026 revenue of $140 million-$160 million, cuts sales outlook to $110 million-$120 million

-   RxSight cut 2026 sales guidance to $110-$120 million from $120-$135 million; raised gross margin outlook to 73%-75% from 70%-72%. \* Forecast 2026 revenue of $140-$160 million, including $30-$40 million from its Alcon collaboration. \* Kept operating expense outlook at the high end of $150-$160 million. \* Preliminary Q2 revenue seen at $32-$34 million, including $5-$7 million from the Alcon collaboration. \* Q2 sales seen at about $27 million on 24,917 LAL units, 11 LDD units; cash about $209 million at June 30. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RxSight Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607061615PRIMZONEFULLFEED9757583) on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [RXST.US](https://longbridge.com/en/quote/RXST.US.md)
- [ALC.US](https://longbridge.com/en/quote/ALC.US.md)

## Related News & Research

- [RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules | RXST Stock News](https://longbridge.com/en/news/293852393.md)
- [Baxter Q2 2026 Earnings Preview](https://longbridge.com/en/news/294224876.md)
- [Hilton Worldwide announces Q3 2026 distribution of R$ 0.02 per unit](https://longbridge.com/en/news/294238525.md)
- [Ciena's Q3 2026 Earnings: What to Expect](https://longbridge.com/en/news/293952665.md)
- [Principal Financial Group declares Q3 2026 distribution of R$ 2.9 per unit, payable Oct. 1](https://longbridge.com/en/news/294099494.md)